| |
- ADAP Waiting Lists in 12 States - (10/30/02)
- CIRRHOSIS: advanced liver disease - (10/30/02)
- Trends in hepatitis C and HIV infection among inmates entering prisons in California, 1994 versus 1999 - (10/30/02)
- End Stage Liver Disease Leading Cause of Death in HCV/HIV Coinfected in France; 46% Had Cirrhosis; 37% had >200 Cd4s & <500 copies/ml viral load - (10/30/02)
- 4th Lipodystrophy Workshop: metabolic abnormalities, HCV/HIV coinfection, fat loss, HCV/HIV coinfection - Michael Dube, MD, Indiana University School of Medicine, ACTG researcher - (10/30/02)
- Abnormal lipids & GGT May Predict Poor Outcome in HCV/HIV Coinfection - (10/29/02)
- ICAAC - HIV Entry Inhibitor: BMS-806 - (10/24/02)
- ICAAC - Quality and Quantity in HIV Treatment: A Discussion of the Quad Therapy Symposium Presented at ICAAC - A Summary by Kimberly Smith MD, MPH For NATAP - (10/24/02)
- ICAAC - Boosted PIs: differences emerging in efficacy, tolerability, lipids. - Graeme Moyle MD, MBBS, Associate Director of HIV Research, Chelsea and Westminster Hospital London, UK. - (10/24/02)
- Adherence in HCV Therapy
- (10/24/02)
- IL-2 SILCAAT Clinical Study Discontinued - (10/24/02)
- ICAAC - TMC-125, a new NNRTI for patients with NNRTI resistance: drug interactions with NNRTIs and protease inhibitors - (10/21/02)
- Risk For Hepatitis C Transmission in Hospital/Clinic Setting: use of multidose medication vials- HCV transmission risk and management of acute HCV in hospital settings - (10/21/02)
- ADAP HIV Drug Price Freeze by Bristol Myers Squibb - (10/21/02)
- My New Liver - By Larry Kramer - (10/21/02)
- Organ Transplants: We Must Have Presumed Consent - By Larry Kramer - (10/21/02)
- Hep C Outbreak at Clinic The Associated Press - (10/17/02)
- FDA Approves Pegasys Monotherapy Today - (10/17/02)
- Hepatitis Cases May Be Linked to Needles at Clinic - By BARRY MEIER - (10/17/02)
- Primary and Secondary Syphilis Among Men Who Have Sex with Men - New York City, 2001: HIV+ MSM leading epidemic - CDC Morbidity and Mortality Weekly Report
- (10/15/02)
- T-20, Fusion Inhibitor and its Availability - Press Release from Roche and Trimeris - (10/15/02)
- ICAAC - Entry Inhibitors & New Test to Identify Co-receptor Use - (10/15/02)
- ICAAC - Switch from d4T to Abacavir: changes in fat and mitochondria - (10/15/02)
- ICAAC - Perspectives on hormonal, mitochondrial and metabolic changes - Reported by Mike Youle, MD, Royal Free Hospital, London - (10/15/02)
- ICAAC - NRTI Sparing Regimens - (10/15/02)
- Warning Issued on Reuse of Needles - (10/11/02)
- ICAAC San Diego 2002: new therapy approaches; hormones and metabolicsReported by Mike Youle, MD, Royal Free Hospital, London - (10/9/02)
- ICAAC - Lipid Analysis in Efavirenz & Nelfinavir Regimens - (10/8/02)
- ICAAC - Switch Study in Children to Efavirenz from Protease Inhibitor - (10/8/02)
- Effect of d4T and AZT on Leg Fat Loss - (10/7/02)
- Barcelona Italian Heart Disease Study Withdrawn - (10/7/02)
- Lipodystrophy, lactic acidosis/acidemia and mitochondrial toxicity issues - Written by Cecilia Shikuma, MD, University of Hawaii and ACTG lipodystrophy researcher
- (10/7/02)
- ICCAC - Resistance to Atazanavir - (10/7/02)
- ICCAC - HIV Healhcare Costs Driven by CD4 Count - (10/7/02)
- ICCAC - Hepatitis C: Can You Replace the Liver Biopsy With Less Invasive Tests - (10/7/02)
- ICCAC - Tenofovir in the Treatment of Individuals Co-Infected with HIV and Hepatitis B Abstract - (10/7/02)
- ICCAC - PegIntron plus Ribavirin vs Interferon plus Rinavirin in HCV/HIV Coinfected Patients: preliminary week 48 results - (10/7/02)
- ICCAC - Kaletra + Amprenavir & Boosted Ritonavir in PI Experiened Patients - (10/7/02)
- ICCAC - Integrase Inhibitors Advancing: S-1360 & metabolic abormalities - (10/1/02)
- ICCAC - T-20 and T-1249 - (10/1/02)
|
